Healthcare RE: Senior Housing, MOBs, and Life Sciences

Introduction

The phrase healthcare real estate suggests a single, defensive asset class: aging demographics, recession-resistant demand, bond-like rent from buildings people cannot stop using. That description fits one corner of the sector and badly misleads on the rest. A hospital-anchored medical office building does behave like a defensive bond. A senior housing community owned through a RIDEA structure does not. There the landlord owns the operating profit-and-loss statement, absorbs wage inflation and occupancy swings directly, and during 2020 and 2021 watched that income collapse. The single variable that organizes the entire sector is operating intensity: how much of the building's business risk the property owner actually holds. Get that one distinction right and the three sub-types fall into place, with net-leased medical office at the defensive end, life sciences in the middle, and senior housing operating portfolios at the far end where real estate becomes an operating business. The three dominant healthcare REITs, Welltower, Ventas, and Healthpeak Properties, sit at different points on that spectrum, which is the simplest explanation for why they trade so differently.

Most property types let an investor draw a clean line between the real estate and the business that occupies it. An office landlord signs a lease, collects rent, and is largely indifferent to whether the tenant's quarter was good or bad until renewal. Healthcare real estate refuses to stay on one side of that line. At one extreme, a net lease to a hospital system or physician group is pure real estate income: the tenant pays a fixed rent plus taxes, insurance, and maintenance, and the landlord's cash flow is a contractual obligation insulated from the tenant's monthly performance. At the other extreme, a senior housing community run as an operating asset hands the landlord the entire income statement, including resident fees on the top line and nursing wages, food, utilities, and insurance below it.

Everything interesting about the sector lives in that range. The choice of where a REIT sits is not incidental; it is the central strategic decision, and it has flipped over the past decade. For years the orthodoxy was to push operating risk onto tenants through long net leases. Since roughly 2023 the Big Three have moved aggressively the other way, converting net-leased senior housing into operating structures so they can capture the upside of a demographic wave directly rather than collecting a flat rent check while the operator keeps the margin expansion. The spectrum is easiest to hold in mind as a few discrete rungs, ordered from least to most operating risk:

From net-lease orthodoxy to operating exposure

The default posture used to be the first rung. Net leasing kept reported cash flow smooth, made portfolios easy to underwrite as bond proxies, and let the REIT grow through sale-leasebacks without staffing up an operating platform. The cost of that simplicity was a hard ceiling: a flat-rent landlord collects modest annual escalators and watches the operator keep every dollar of margin expansion when the business improves. RIDEA, enacted in 2007, removed the legal barrier to capturing that upside, but most REITs stayed net-lease-heavy until the senior housing demographic case became overwhelming. The post-2023 conversions are the sector deciding, collectively, that the demographic wave is large enough to justify trading a smooth rent stream for direct operating exposure.

That pivot only works because of the structure that makes it legal. A REIT generally cannot earn operating income from running a business; its income has to be passive rent, interest, or gains. The workaround is a taxable REIT subsidiary, the entity a REIT uses to hold operating activities without breaking its REIT qualification tests. Senior housing operating structures route resident revenue through exactly that vehicle, which is why the topic is impossible to separate from REIT tax mechanics.

RIDEA

The REIT Investment Diversification and Empowerment Act of 2007 lets a REIT take the operating income of a senior housing or healthcare property through a taxable REIT subsidiary, rather than collecting only a fixed lease payment. Under a RIDEA structure the REIT hires an independent manager to run the building but keeps the upside (and downside) of the property's actual cash flow.

The practical consequence is a sliding scale of volatility. Net-leased healthcare assets produce some of the steadiest cash flow in commercial real estate. Operating structures produce something closer to the earnings of a hospitality or services company, with strong operating leverage in both directions. A banker pitching a healthcare REIT, underwriting a portfolio, or building a valuation has to locate each asset on this spectrum before any number means anything.

Senior housing is the sub-type that breaks the bond-like stereotype, and it is where most of the sector's recent capital and deal activity has concentrated. The category spans independent living, assisted living, and memory care, and it sits upstream of skilled nursing on the acuity ladder. What unites these formats is that the building is inseparable from a labor-intensive service operation. Residents are paying for care, meals, and staffing as much as for shelter, and roughly seventy percent of the cost base is people. That makes the asset acutely sensitive to wages, and healthcare labor has been under sustained pressure: industry quit rates have averaged about 1.5 million per quarter since early 2020, against roughly 900,000 per quarter in the preceding decade.

The structural choice in senior housing is binary and consequential. A REIT can hold a community on a triple-net lease, collecting a fixed rent from an operator who keeps all the residual margin, or it can hold it through an operating structure and take the property's actual income. The first option is defensive and capped. The second is the one the Big Three have been racing toward.

SHOP (Seniors Housing Operating Portfolio)

A SHOP is the segment of a healthcare REIT's portfolio held through a RIDEA operating structure rather than a net lease. The REIT reports the community's full revenue and operating expenses and earns the net operating income directly, making SHOP results a window into the underlying senior housing business rather than a contractual rent stream.

Why the demographic case is so strong right now

The demand story is unusually clean. The 80-plus population, the core customer for assisted living and memory care, is entering a multi-decade surge as the older Baby Boomers age into it. Supply has moved the opposite way. New construction starts have collapsed to roughly 1,200 units in a recent quarter, near record lows, because development financing froze when rates rose and construction costs spiked. A growing customer base meeting almost no new supply is the textbook setup for pricing power, and it has shown up as double-digit same-store net operating income growth in the best operating portfolios. The 65-plus demand wave is the demographic engine the entire investment thesis rests on.

Why operating exposure cuts both ways

The catch is that capturing that growth means owning the operating risk, and operating leverage is symmetric. A community running at high occupancy throws off expanding margins as rate increases outpace fixed costs. The same community losing a few hundred basis points of occupancy, or absorbing a wage spike, can see net operating income fall far faster than revenue. The pandemic demonstrated this brutally: SHOP income across the sector cratered as occupancy dropped and infection-control costs surged, while net-leased portfolios kept paying. The current enthusiasm for operating exposure is a bet that the demographic tailwind is now strong enough to make the upside worth the volatility.

The operator is the asset

In an operating structure the REIT does not run the building itself; it hires an independent manager and shares in the property's economics. That makes the choice of manager a genuine source of value rather than an administrative detail. Two identical communities under different operators can produce materially different occupancy, rate growth, and margins, because senior housing is a local, reputation-driven, execution-heavy business. National operators such as Brookdale Senior Living, Atria Senior Living, and Sunrise Senior Living anchor large blocks of REIT-owned communities, and REITs increasingly spread exposure across a roster of regional managers to avoid single-operator concentration. When a manager underperforms, the REIT can transition the community to a stronger operator, a lever that simply does not exist under a net lease. Operator selection, in other words, is part of the underwriting, not a downstream consequence of it.

The deeper point for a banker is that senior housing valuation is not a cap-rate-on-rent exercise. It is the valuation of an operating business with a real estate wrapper, which is why underwriting operator risk and the RIDEA-versus-net-lease decision is treated as its own discipline rather than a footnote to property valuation.

If senior housing is the volatile end of the spectrum, medical office buildings are the ballast. An MOB is exactly what the name suggests: outpatient clinical space, often physician practices, imaging centers, and ambulatory surgery, frequently located on or near a hospital campus. The economics are defensive for reasons that compound. Healthcare delivery has shifted decisively from inpatient hospital settings to lower-cost outpatient settings, so the demand backdrop is structurally growing. Tenants are sticky because relocating a medical practice means moving specialized buildout, disrupting patient referral patterns, and potentially severing the relationship with an anchor hospital system. Retention rates run far higher than in conventional office.

That stickiness shows up in pricing. Medical outpatient buildings have traded at a persistent premium to general office, reaching roughly $298 per square foot against about $197 per square foot for general office in a recent quarter, a premium of about fifty percent. While conventional office has been in structural distress since 2020, MOBs have held occupancy and value, which is why the sub-type is often described as the recession-resistant core of a healthcare REIT's portfolio.

A useful distinction within the sub-type is on-campus versus off-campus. On-campus buildings sit on or adjacent to a hospital, draw their demand from the affiliated system, and command the tightest cap rates because the location is effectively irreplaceable. Off-campus buildings serve the same outpatient shift but depend more on the strength of the individual practices inside them, so they trade wider. The broad migration of procedures out of expensive inpatient settings into ambulatory surgery centers and outpatient clinics has lifted demand for both, and the consolidation of independent physician practices into large health systems has strengthened the credit behind a growing share of MOB leases.

The strategic question in MOBs is therefore less about volatility and more about scale and relationships. Value accrues to owners who control the buildings around a hospital campus and can offer a health system a single landlord across its outpatient footprint. The depth of hospital-system relationships and tenant retention that drive MOB economics is the real moat, and it is why the sub-type rewards specialized operators over generalist buyers.

Life sciences real estate looks superficially like office but behaves like a cyclical bet on a single end market. The product is specialized laboratory space: buildings engineered for high power loads, heavy ventilation, vibration control, and chemical handling, clustered in a handful of research hubs around Boston, San Francisco, and San Diego. The tenants are pharmaceutical and biotechnology companies, and that tenant base is the whole story. Lab demand tracks biotech funding, which tracks venture capital flows, public biotech equity windows, and government research budgets. When that funding is abundant, lab space is scarce and rents soar. When it dries up, the sector discovers it built too much.

When the funding cycle turns

The current cycle is a case study in that whipsaw. After a funding boom drove a record development pipeline, demand reversed. Nationwide lab vacancy has climbed to roughly 27%, with Boston, San Francisco, and San Diego all running vacancy in the high-20s to around thirty percent and asking rents in the top markets down more than 10% from their 2022 peak. Tenant demand in those top markets has dropped around sixty percent from its 2021 peak. JLL has projected that nearly 19 million square feet of lab space could be converted to other uses by 2030, an admission that a meaningful slice of the boom-era pipeline will never lease as lab.

The sector bellwether shows what that does to a landlord. Alexandria Real Estate Equities, the dominant life sciences REIT, posted a third-quarter net loss of roughly $234.9 million, saw occupancy slip to 90.6% from 94.7% a year earlier, and reported same-property net operating income down 6.0% year over year on a GAAP basis as space lingered and re-leasing slowed.

The other defining feature is geographic concentration. Lab demand clusters around research universities, teaching hospitals, and the venture ecosystems that fund spinouts, which is why a handful of submarkets in Cambridge, South San Francisco, and San Diego account for a disproportionate share of institutional-quality lab space. That clustering is a strength in a boom, because tenants want to be near talent and collaborators, and a liability in a bust, because oversupply in those same few markets has nowhere else to go. The conversions JLL has flagged are concentrated precisely in the boom-era buildings that landed in the weakest locations with the thinnest tenant rosters.

What separates winners from losers in a downturn is tenant credit and campus quality. Portfolios anchored by large-cap pharma and well-capitalized public biotech weather a funding winter; portfolios full of pre-revenue startups burning venture cash do not. The discipline of reading lab demand through the biotech funding cycle is what makes life sciences the highest-beta corner of healthcare real estate.

The reason healthcare REITs trade at such different multiples is that each one blends these sub-types differently, and the blend determines how much operating risk the equity carries. The three sub-types compare cleanly across the variables that matter to an underwriter.

The table omits one further sub-type that sits at the highest-acuity, most regulated end: skilled nursing and post-acute facilities, where rent ultimately depends on Medicare and Medicaid reimbursement rather than private-pay residents. The Big Three have largely exited direct skilled nursing ownership, leaving it to specialists, precisely because reimbursement policy rather than real estate fundamentals drives the underwriting. Its presence at the edge of the sector is a reminder that operating intensity is only one axis; payer mix and regulatory exposure are another, and they peak in skilled nursing.

Welltower has tilted hardest toward senior housing operating exposure, converting large blocks of net-leased communities into RIDEA structures and committing roughly $14 billion to new senior housing acquisitions, spanning more than 700 communities and over 46,000 units across the United States, United Kingdom, and Canada, to ride the demographic wave directly. Ventas has followed a parallel path, leaning into senior housing operating portfolios while retaining MOB and life sciences exposure. Healthpeak, having earlier exited senior housing to concentrate on outpatient medical and lab, reversed course and announced the spin-off of a dedicated senior housing vehicle, Janus Living, signaling that even a REIT that left the business sees the operating opportunity as too large to ignore. The result is that the same demographic thesis is being expressed through very different risk profiles across the Big Three, and the recent wave of senior housing M&A and the Janus spin-off is the clearest evidence of where the sector's conviction now lies.

One boundary is worth drawing clearly. Healthcare real estate is the buildings and the property-owning entities, not the care providers or drug developers themselves. The hospital systems that anchor MOBs and the biotech tenants that fill lab space are covered on the operating side of healthcare investment banking, a different discipline with its own reimbursement, clinical, and regulatory analysis. The real estate banker's job is to value and finance the bricks and the income they produce, while staying fluent enough in the operating businesses to underwrite the tenants and operators who ultimately pay the rent. That dual fluency, real estate mechanics plus a working grasp of healthcare operations, is exactly what makes the sub-sector a distinct specialty rather than a footnote to either real estate or healthcare coverage.